Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine

BACKGROUND: Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzanakaki, Georgina, Hong, Eva, Kesanopoulos, Konstatinos, Xirogianni, Athanasia, Bambini, Stefania, Orlandi, Luca, Comanducci, Maurizio, Muzzi, Alessandro, Taha, Muhamed-Kheir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018652/
https://www.ncbi.nlm.nih.gov/pubmed/24779381
http://dx.doi.org/10.1186/1471-2180-14-111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018652/
https://www.ncbi.nlm.nih.gov/pubmed/24779381
http://dx.doi.org/10.1186/1471-2180-14-111

Ejemplares similares